Introducing the new AltIndexLearn more
Intellia Therapeutics

Intellia Therapeutics (NTLA) Earnings Prediction

Updated August 11, 2026 · AltIndex alt-data view going into the print

AltIndex AI Score on Intellia Therapeutics is 36 — signals lean bearish heading into the print. Underlying trend: 7 tracked signals showing mixed direction over the last 3 months.

Next report
Wednesday, November 4, 2026
EPS Estimate
$-0.99
AltIndex AI Score
36
AI Prediction
Signals bearish into print

NTLA stock price — last 3 months

Intellia Therapeutics (NTLA) is trading at $12.02, down 15.8% over the last 3 months (from $14.28 three months ago).

What the alt-data signals say about Intellia Therapeutics right now

Trends across the last 3 months — the run-up to Intellia Therapeutics’s next earnings print.

Signal Current 3-month change
Job postings 64 ↑ +82.9%
LinkedIn headcount 506 ↑ +9.3%
Sentiment 67% Bullish ↓ -17pp
Web traffic 37,473 ↓ -34.4%
Employee business outlook 33% Negative → flat
Instagram followers 1,429 → +2.7%
X followers 12,208 → +0.4%

Full daily-resolution trend charts on every signal are on the NTLA ticker page.

Get alerted when NTLA signals inflect

AltIndex stock alerts fire when alt-data on NTLA breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.

Sign up to AltIndex →

Intellia Therapeutics earnings: frequently asked questions

When does Intellia Therapeutics report earnings next?
Intellia Therapeutics (NTLA) is scheduled to report next earnings on Wednesday, November 4, 2026. The exact pre-market or post-market time is set by the company a few days ahead; see the official investor-relations page for confirmation.
What does the AltIndex AI Score say about Intellia Therapeutics going into earnings?
Current AI Score on Intellia Therapeutics: 36 — Signals bearish into print. The AI Score combines 10,000+ alternative-data and financial signals into one 0–100 number; higher = signals lean bullish, lower = signals lean bearish. Full per-signal breakdown is on the NTLA ticker page.
What is the EPS estimate for Intellia Therapeutics?
Analyst consensus EPS estimate for Intellia Therapeutics’s next quarter: $-0.99. We refresh this from analyst-estimate data daily.
How accurate are AltIndex’s earnings predictions for Intellia Therapeutics?
AltIndex doesn’t predict the exact EPS number — the alt-data signals don’t see the financials. What the signals can do is tell you whether the underlying business momentum (web traffic, hiring, social audience, sentiment) supports the analyst consensus or contradicts it. AltIndex publishes the full pick history at altindex.com/results — including the misses — so you can verify how the signal-driven calls have performed.
Where can I see the full signal breakdown on Intellia Therapeutics?
Visit https://altindex.com/ticker/ntla for the complete per-signal view: AI Score history, web traffic trend chart, 8-platform social audience tracking, hiring activity, news mention volume, sentiment scoring, insider trades and Congressional disclosures.
How can I get alerted before Intellia Therapeutics reports earnings?
AltIndex stock alerts fire when alt-data signals on a stock break out of their historical range — often days or weeks before the earnings number confirms it. Add NTLA to your watchlist and you’ll get notified when its signals shift. See altindex.com/stock-alerts for the full alert categories.

See every alt-data signal on NTLA

Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Intellia Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.

Sign up to AltIndex → Log in